Gaston-Dreyfus Remi 4
4 · Bionik Laboratories Corp. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Purchase
Common Stock, par value $0.001 per share
2023-06-09$0.60/sh+180,555$108,333→ 1,814,871 total(indirect: Shares held through GD Holdings and Lombard International Assurance SA)
Holdings
- 61,256
Common Stock, par value $0.001 per share
Footnotes (2)
- [F1]The reporting person acquired the shares of common stock in lieu of cash payment of $108,333 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.
- [F2]Includes 17,476 exchangeable shares of the Issuer's subsidiary.